» Articles » PMID: 35328222

Sclerodermic Cardiomyopathy-A State-of-the-Art Review

Overview
Specialty Radiology
Date 2022 Mar 25
PMID 35328222
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic sclerosis (SSc) is a chronic autoimmune disorder with unknown triggering factors, and complex pathophysiologic links which lead to fibrosis of skin and internal organs, including the heart, lungs, and gut. However, more than 100 years after the first description of cardiac disease in SSc, sclerodermic cardiomyopathy (SScCmp) is an underrecognized, occult disease with important adverse long-term prognosis. Laboratory tests, electrocardiography (ECG) and cardiovascular multimodality imaging techniques (transthoracic 2D and 3D echocardiography, cardiac magnetic resonance (CMR), and novel imaging techniques, including myocardial deformation analysis) provide new insights into the cardiac abnormalities in patients with SSc. This state-of-the-art review aims to stratify all the cardiac investigations needed to diagnose and follow-up the SScCmp, and discusses the epidemiology, risk factors and pathophysiology of this important cause of morbidity of the SSc patient.

Citing Articles

Acute Systemic Sclerosis-Associated Cardiomyopathy That Improved With Glucocorticoids and Cyclophosphamide.

Gustafson A, Trinh K, Lomasney J, Shah S, Hinchcliff M JACC Case Rep. 2025; 30(4):102948.

PMID: 39972702 PMC: 11862153. DOI: 10.1016/j.jaccas.2024.102948.


Cardiopulmonary Exercise Testing: Deciphering Cardiovascular Complications in Systemic Sclerosis.

Giubertoni A, Bellan M, Cumitini L, Patti G Rev Cardiovasc Med. 2025; 26(1):25914.

PMID: 39867169 PMC: 11759969. DOI: 10.31083/RCM25914.


Non-Invasive Cardiac and Vascular Monitoring in Systemic Sclerosis: Impact of Therapy on Subclinical Dysfunction.

Magda S, Gheorghiu A, Mincu R, Ciobanu A, Constantinescu T, Popa E Medicina (Kaunas). 2025; 60(12.

PMID: 39768959 PMC: 11678526. DOI: 10.3390/medicina60122080.


Anti-SRP Antibodies and Myocarditis in Systemic Sclerosis Overlap Syndrome with Immune-Mediated Necrotizing Myositis (IMNM).

Alexandru C, Donisa A, Bobirca F, Dascalu A, Dumitrescu D, Ancuta I Medicina (Kaunas). 2024; 60(11).

PMID: 39596941 PMC: 11596468. DOI: 10.3390/medicina60111756.


Systemic sclerosis and acute heart failure in prosthetic heart valve patients: A retrospective analysis.

Khattar G, Wei C, Davis A, Saliba F, Aoun L, Mourad O J Scleroderma Relat Disord. 2024; :23971983241278853.

PMID: 39544905 PMC: 11559524. DOI: 10.1177/23971983241278853.


References
1.
Champion H . The heart in scleroderma. Rheum Dis Clin North Am. 2008; 34(1):181-90. PMC: 2361099. DOI: 10.1016/j.rdc.2007.12.002. View

2.
Kahan A, Coghlan G, McLaughlin V . Cardiac complications of systemic sclerosis. Rheumatology (Oxford). 2009; 48 Suppl 3:iii45-8. DOI: 10.1093/rheumatology/kep110. View

3.
Seferovic P, Ristic A, Maksimovic R, Simeunovic D, Ristic G, Radovanovic G . Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford). 2006; 45 Suppl 4:iv39-42. DOI: 10.1093/rheumatology/kel315. View

4.
Lambova S . Cardiac manifestations in systemic sclerosis. World J Cardiol. 2014; 6(9):993-1005. PMC: 4176808. DOI: 10.4330/wjc.v6.i9.993. View

5.
Karabay C, Karaahmet T, Tigen K . Cardiovascular involvement in patients with systemic sclerosis: insights from electromechanical characteristics of the heart. Anadolu Kardiyol Derg. 2011; 11(7):643-7. DOI: 10.5152/akd.2011.170. View